Entresto 49 MG-51 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F6SF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,128
Award facts
- Contract value 100% obligated
- $35,127.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,127.54 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count units). This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly the military and veteran medical supply chains.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract facilitates medical procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating AmerisourceBergen's critical role in the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F6SF3?
SPE2DR26F6SF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F6SF3 worth?
The government has obligated $35,128 on SPE2DR26F6SF3.
Is contract SPE2DR26F6SF3 an order under another contract?
Yes. SPE2DR26F6SF3 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SF3 competed?
The extent of competition for SPE2DR26F6SF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award